|
Regenerative Medicine
|
US$
75 |
|
Nov-2021 |
Doc #35478 |
|
| Printed Page Length :
15
pages |
| Number of Tables :
3 |
| Number of Figures:
1 |
|
Market Overview
|
|
Given the government’s commitment to new policies, the existing cell storage business will continue to grow steadily, accelerate clinical progress in the cell therapy program, and strengthen the competitiveness of Taiwan’s contract manufacturing organizations. As a result, the industry climate is expected to be favorable in 2022.
|
|
|
|